89 related articles for article (PubMed ID: 373425)
1. BCG treatment of Crohn's disease.
Rahban S; Sherman JH; Opelz G; Conley DR; Panish JF; Marks JW; Terasaki PI; Schoenfield LJ
Am J Gastroenterol; 1979 Feb; 71(2):196-201. PubMed ID: 373425
[TBL] [Abstract][Full Text] [Related]
2. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
[TBL] [Abstract][Full Text] [Related]
3. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
[TBL] [Abstract][Full Text] [Related]
4. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
[TBL] [Abstract][Full Text] [Related]
6. Studies of cell-mediated immunity in patients with Crohn's disease.
Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
[TBL] [Abstract][Full Text] [Related]
7. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
Reinisch W; Hommes DW; Van Assche G; Colombel JF; Gendre JP; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer SJ; Rutgeerts P; Pearce T
Gut; 2006 Aug; 55(8):1138-44. PubMed ID: 16492717
[TBL] [Abstract][Full Text] [Related]
8. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
[TBL] [Abstract][Full Text] [Related]
9. Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial.
Fukuda Y; Takazoe M; Sugita A; Kosaka T; Kinjo F; Otani Y; Fujii H; Koganei K; Makiyama K; Nakamura T; Suda T; Yamamoto S; Ashida T; Majima A; Morita N; Murakami K; Oshitani N; Takahama K; Tochihara M; Tsujikawa T; Watanabe M
Am J Gastroenterol; 2008 Jul; 103(7):1721-9. PubMed ID: 18616656
[TBL] [Abstract][Full Text] [Related]
10. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
Sachar DB; Rubin KP; Gumaste V
Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis: a randomized, double blind, placebo-controlled study.
Li J; Luo DF; Li SY; Sun BQ; Zhong NS
Chin Med J (Engl); 2005 Oct; 118(19):1595-603. PubMed ID: 16232343
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
Moertel CG; Ritts RE; Schutt AJ; Hahn RG
Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
[TBL] [Abstract][Full Text] [Related]
13. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
[TBL] [Abstract][Full Text] [Related]
15. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Crohn's disease with azathioprine: a controlled evaluation.
Klein M; Binder HJ; Mitchell M; Aaronson R; Spiro H
Gastroenterology; 1974 May; 66(5):916-22. PubMed ID: 4597093
[No Abstract] [Full Text] [Related]
17. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
[TBL] [Abstract][Full Text] [Related]
18. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
[TBL] [Abstract][Full Text] [Related]
19. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
20. Preliminary investigation on humoral and cellular immune responses to selected food proteins in patients with Crohn's disease.
Frieri M; Claus M; Boris M; Zitt M; Scalise D; Harris N
Ann Allergy; 1990 Apr; 64(4):345-51. PubMed ID: 2321808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
